Psychiatry Research

• 

  Publication Venue For

  • Evaluating Suicide Risk Using the Reasons for Dying-Reasons for Living (RFD-RFL) Index in a Military Psychiatric Inpatient Setting..  295:113576. 2021
  • Overconfidence in false autobiographical memories in patients with schizophrenia..  279:374-375. 2019
  • Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study..  275:238-246. 2019
  • Exploration of NO₂ and PM_2.5 air pollution and mental health problems using high-resolution data in London-based children from a UK longitudinal cohort study..  272:8-17. 2019
  • Childhood maltreatment and impulsivity as predictors of interpersonal violence, self-injury and suicide attempts: A national study..  269:386-393. 2018
  • Replication analysis for composition of the Delirium Motor Subtype Scale (DMSS) in a referral cohort from Northern India..  206:68-74. 2013
  • AGTR1 gene variation: association with depression and frontotemporal morphology..  202:104-109. 2012
  • Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards..  194:263-270. 2011
  • Reduced amygdala-orbitofrontal connectivity during moral judgments in youths with disruptive behavior disorders and psychopathic traits..  194:279-286. 2011
  • Reduction of dorsolateral prefrontal cortex gray matter in late-life depression..  193:1-6. 2011
  • fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence..  192:167-175. 2011
  • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis..  187:42-48. 2011
  • Temporo-parietal junction stimulation in the treatment of depersonalization disorder..  186:138-140. 2011
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome..  178:433-436. 2010
  • Clinical utility of the Primary Care--PTSD Screen among U.S. veterans who served since September 11, 2001..  178:330-335. 2010
  • The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia..  178:33-38. 2010
  • Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome..  181:1-8. 2010
  • White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: a diffusion tensor imaging study..  172:121-127. 2009
  • Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology..  172:7-15. 2009
  • Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression..  172:49-54. 2009
  • Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder..  172:61-67. 2009
  • Statistical procedures for analyzing mental health services data..  160:129-136. 2008
  • Hippocampal volumes and depression subtypes..  163:126-132. 2008
  • Prefrontal mechanisms for executive control over emotional distraction are altered in major depression..  163:143-155. 2008
  • Age-dependent reduction of amygdala volume in bipolar disorder..  163:84-94. 2008
  • Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial..  159:115-120. 2008
  • Modification effects of coping on post-traumatic morbidity among earthquake rescuers..  158:164-171. 2008
  • Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity..  157:259-263. 2008
  • Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans..  162:59-72. 2008
  • Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syndrome..  153:171-177. 2007
  • An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials..  152:293-297. 2007
  • The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults..  155:173-177. 2007
  • Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale..  151:249-254. 2007
  • Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms..  145:215-223. 2006
  • Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls..  144:99-108. 2006
  • Differences in brain volumes among males and female hormone-therapy users and nonusers..  147:127-134. 2006
  • Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial..  141:193-200. 2006
  • Striatal dopamine D2/D3 receptor availability in male smokers..  146:87-90. 2006
  • Brief psychiatric rating scale expanded version: How do new items affect factor structure?.  135:217-228. 2005
  • Probing reward function in post-traumatic stress disorder with beautiful facial images..  135:179-183. 2005
  • Greater MRI lesion volumes in elderly depressed subjects than in control subjects..  139:1-7. 2005
  • Functional changes in the activity of brain regions underlying emotion processing in the elderly..  139:9-18. 2005
  • A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia..  133:129-133. 2005
  • Factors that differentiate early vs. later onset of major depression disorder..  129:127-140. 2004
  • Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder..  127:137-145. 2004
  • CSF CRH in abstinent cocaine-dependent patients..  117:277-280. 2003
  • Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project..  117:167-175. 2003
  • Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography..  116:173-185. 2002
  • Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects..  115:63-77. 2002
  • MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex..  114:149-161. 2002
  • Evidence for altered cerebellar vermis neuronal integrity in schizophrenia..  107:125-134. 2001
  • Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder..  101:131-136. 2001
  • A comparison of alternative assessments of depressive symptom severity: a pilot study..  96:269-279. 2000
  • Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders..  95:215-225. 2000
  • Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls..  95:201-213. 2000
  • A comparison of alternative assessments of depressive symptom severity: a pilot study..  95:55-65. 2000
  • Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome..  89:73-95. 1999
  • Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder..  88:63-70. 1999
  • Clinical, demographic and social characteristics of psychotic depression..  86:99-106. 1999
  • Characteristics of norepinephrine and clonidine displacement of [3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers..  85:305-314. 1999
  • Magnetic-resonance morphometry in patients with major depression..  84:7-15. 1998
  • Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients..  83:95-103. 1998
  • Quantitative analysis of T2 signal intensities in Alzheimer's disease..  82:181-185. 1998
  • Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy..  82:95-106. 1998
  • Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder..  73:33-45. 1997
  • Psychosocial and physical correlates of chronic depression..  72:149-159. 1997
  • Intracranial and extracranial blood flow during acute anxiety..  74:93-107. 1997
  • Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness.  73:109-113. 1997
  • Magnetic resonance imaging changes in putamen nuclei iron content and distribution in normal subjects..  68:55-61. 1996
  • Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method..  67:215-234. 1996
  • Effect of ECT treatment number on the ictal EEG..  62:179-189. 1996
  • MRI changes in schizophrenia in late life: a preliminary controlled study..  60:117-123. 1996
  • Growth hormone response to baclofen: a comparison of 10-mg and 20-mg doses in healthy men..  60:41-47. 1996
  • Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders.  60:49-56. 1996
  • Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder..  59:127-136. 1995
  • A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging..  61:53-60. 1995
  • Geniculocalcarine hyperintensities on brain magnetic resonance imaging associated with visual hallucinations in the elderly..  54:283-293. 1994
  • Ipsilateral subcortical atrophy associated with temporal lobectomy..  54:295-304. 1994
  • Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods..  55:167-177. 1994
  • Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests..  53:1-12. 1994
  • Can state and trait variables be disentangled? A methodological framework for psychiatric disorders..  52:55-69. 1994
  • Magnetic resonance imaging in social phobia..  52:35-42. 1994
  • Effects of marijuana on performance of a computerized cognitive-neuromotor test battery..  51:115-125. 1994
  • Regional cerebral blood flow alterations in unipolar depression..  50:233-256. 1993
  • Tridimensional Personality Questionnaire and serotonin in bulimia nervosa..  48:9-15. 1993
  • Hypercortisolemia and hippocampal changes in depression..  47:163-173. 1993
  • Prospective assessment of electroencephalographic sleep in remitted major depression..  46:269-284. 1993
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms..  44:153-165. 1992
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder..  44:141-151. 1992
  • In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients..  44:63-70. 1992
  • Comparison of the delta EEG in the first and second non-REM periods in depressed adults and normal controls..  41:65-72. 1992
  • A magnetic resonance imaging study of putamen nuclei in major depression.  40:95-99. 1991
  • Occurrence of subcortical hyperintensities in elderly subjects with mania..  40:211-220. 1991
  • A magnetic resonance imaging study of putamen nuclei in major depression..  40:95-99. 1991
  • Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow..  40:125-134. 1991
  • Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients..  38:285-292. 1991
  • Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report..  37:245-260. 1991
  • Does the pretreatment polysomnogram predict response to cognitive therapy in depressed outpatients? A preliminary report..  33:285-299. 1990
  • Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals..  33:179-188. 1990
  • Effects of bright light on responsiveness to a muscarinic agonist in rats selectively bred for endogenously increased cholinergic function..  33:139-150. 1990
  • Cerebral blood flow responses to CO2 and acetazolamide: the effect of anxiety..  28:241-242. 1989
  • Polysomnographic parameters in first-degree relatives of unipolar probands..  27:127-136. 1989
  • Sex roles and regional cerebral blood flow..  27:55-64. 1989
  • Behavioral indications for serotonin receptor hypersensitivity in panic disorder..  25:101-104. 1988
  • Cerebral blood flow changes induced by CO2 in anxiety..  23:285-294. 1988
  • A comparative evaluation of three discriminant scales for endogenous depression..  23:193-200. 1988
  • Which depressions respond to placebo?.  18:217-226. 1986
  • The Inventory for Depressive Symptomatology (IDS): preliminary findings..  18:65-87. 1986
  • Weight change in depression..  17:275-283. 1986
  • Suppression of cortisol following dexamethasone in demented patients..  17:173-182. 1986
  • Forms of atypical depression and their response to antidepressant drugs..  17:87-95. 1986
  • A controlled study of cellular immune function in affective disorders before and during somatic therapy..  15:185-193. 1985
  • TRH-induced prolactin release is blunted in females with endogenous unipolar major depression..  12:321-331. 1984
  • Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment..  12:69-77. 1984
  • Urinary excretion of biopterin and neopterin in psychiatric disorders..  11:83-89. 1984
  • The thyrotropin-releasing hormone stimulation test: a methodological study..  9:59-67. 1983
  • Recommendations for depression publications..  8:238-241. 1983
  • The effect of dosage on the dexamethasone suppression test in normal controls..  7:277-285. 1982
  • Research issues in psychological studies of chronic dialysis..  3:307-314. 1980
  • Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. 1998